BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26523883)

  • 1. Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.
    Osawa T; Hafez KS; Miller DC; Montgomery JS; Morgan TM; Palapattu GS; Weizer AZ; Caoili EM; Ellis JH; Kunju LP; Wolf JS
    J Urol; 2016 Mar; 195(3):574-80. PubMed ID: 26523883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of renal mass biopsy risk stratification algorithm for robotic partial nephrectomy--could a biopsy have guided management?
    Rahbar H; Bhayani S; Stifelman M; Kaouk J; Allaf M; Marshall S; Zargar H; Ball MW; Larson J; Rogers C
    J Urol; 2014 Nov; 192(5):1337-42. PubMed ID: 24936720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology.
    Halverson SJ; Kunju LP; Bhalla R; Gadzinski AJ; Alderman M; Miller DC; Montgomery JS; Weizer AZ; Wu A; Hafez KS; Wolf JS
    J Urol; 2013 Feb; 189(2):441-6. PubMed ID: 23253955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications.
    Seideman CA; Gahan J; Weaver M; Olweny EO; Richter M; Chan D; Cadeddu JA
    BJU Int; 2013 Dec; 112(8):1121-4. PubMed ID: 24053576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor complexity predicts malignant disease for small renal masses.
    Mullins JK; Kaouk JH; Bhayani S; Rogers CG; Stifelman MD; Pierorazio PM; Tanagho YS; Hillyer SP; Kaczmarek BF; Chiu Y; Allaf ME
    J Urol; 2012 Dec; 188(6):2072-6. PubMed ID: 23083863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-risk Vs High-risk Renal Tumors.
    Osawa T; Hafez KS; Miller DC; Montgomery JS; Morgan TM; Palapattu GS; Weizer AZ; Caoili EM; Ellis JH; Kunju LP; Wolf JS
    Urology; 2016 Oct; 96():87-92. PubMed ID: 27262393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Boorjian SA; Carter RE; Geske JR; Callstrom MR; Atwell TD
    J Urol; 2013 Jan; 189(1):30-5. PubMed ID: 23164375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates.
    Lane BR; Golan S; Eggener S; Tobert CM; Kahnoski RJ; Kutikov A; Smaldone M; Whelan CM; Shalhav A; Uzzo RG
    J Urol; 2013 Jun; 189(6):2047-53. PubMed ID: 23313207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal lesions with low R.E.N.A.L nephrometry score are associated with more indolent renal cell carcinomas (RCCs) or benign histology: findings in an Australian cohort.
    Satasivam P; Sengupta S; Rajarubendra N; Chia PH; Munshey A; Bolton D
    BJU Int; 2012 Apr; 109 Suppl 3():44-7. PubMed ID: 22458493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.
    Kutikov A; Smaldone MC; Egleston BL; Manley BJ; Canter DJ; Simhan J; Boorjian SA; Viterbo R; Chen DY; Greenberg RE; Uzzo RG
    Eur Urol; 2011 Aug; 60(2):241-8. PubMed ID: 21458155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is surveillance of small renal masses safe in the elderly?
    O'Malley RL; Godoy G; Phillips CK; Taneja SS
    BJU Int; 2010 Apr; 105(8):1098-101. PubMed ID: 19849693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and radiographic characteristics governing the selection of therapy of small renal masses.
    Jackson M; Cusano A; Haddock P; Staff I; Abarzua-Cabezas F; Kesler S; Meraney A; Shichman S
    Can J Urol; 2014 Dec; 21(6):7529-35. PubMed ID: 25483759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility and fidelity of the R.E.N.A.L. nephrometry score.
    Montag S; Waingankar N; Sadek MA; Rais-Bahrami S; Kavoussi LR; Vira MA
    J Endourol; 2011 Dec; 25(12):1925-8. PubMed ID: 21988126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between R.E.N.A.L. nephrometry score and survival outcomes in renal tumours.
    Zhang X; Sun Q; Qi Y; Chen Y; Xiong Y; Xi W; Miao Z; Li X; Quan X; Lin J
    Jpn J Clin Oncol; 2024 Mar; 54(3):339-345. PubMed ID: 38117949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth.
    Kutikov A; Uzzo RG
    J Urol; 2009 Sep; 182(3):844-53. PubMed ID: 19616235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass.
    Canter D; Kutikov A; Manley B; Egleston B; Simhan J; Smaldone M; Teper E; Viterbo R; Chen DY; Greenberg RE; Uzzo RG
    Urology; 2011 Nov; 78(5):1089-94. PubMed ID: 22054378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.
    Ball MW; Gorin MA; Bhayani SB; Rogers CG; Stifelman MD; Kaouk JH; Zargar H; Marshall S; Larson JA; Rahbar HM; Trock BJ; Pierorazio PM; Allaf ME
    Urol Oncol; 2015 Mar; 33(3):112.e9-14. PubMed ID: 25499258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in Nephrometry Scoring in Small Renal Masses (<4 cm) on Active Surveillance: Preliminary Observations From Tayside Active Surveillance Cohort (TASC) Study.
    Mohammed KH; Wanzhe Z; Catherine P; Magda SB; Lang S; Ghulam N
    Acad Radiol; 2018 Nov; 25(11):1381-1387. PubMed ID: 29523459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.